mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.01 |
mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.01 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.02 |
mRNA |
Gemcitabine |
GDSC1000 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
FMK |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
KU-60019 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
GDC-0449 |
GDSC1000 |
pan-cancer |
AAC |
0.078 |
0.02 |
mRNA |
Docetaxel |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.03 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.04 |